No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / secondary
-
Administration, Topical
-
Allopurinol / administration & dosage
-
Allopurinol / therapeutic use
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / adverse effects*
-
Angiogenesis Inhibitors / therapeutic use
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Colonic Neoplasms / drug therapy
-
Colonic Neoplasms / pathology
-
Drug Eruptions / diagnosis*
-
Drug Eruptions / drug therapy
-
Drug Eruptions / etiology*
-
Free Radical Scavengers / administration & dosage
-
Free Radical Scavengers / therapeutic use
-
Humans
-
Injections, Intravenous
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / secondary
-
Male
-
Middle Aged
-
Ointments
-
Treatment Outcome
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Free Radical Scavengers
-
Ointments
-
Bevacizumab
-
Allopurinol